Skip to main content
Journal cover image

A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs.

Publication ,  Journal Article
Halpern, SE; McConnell, A; Peskoe, SB; Raman, V; Jawitz, OK; Choi, AY; Neely, ML; Palmer, SM; Hartwig, MG
Published in: Am J Transplant
March 2021

Lungs from "nonideal," but acceptable donors are underutilized; however, organ procurement organization (OPO) metrics do not reflect the extent to which OPO-specific practices contribute to these trends. We developed a comprehensive system to evaluate nonideal lung donor avoidance, or risk aversion among OPOs. Adult donors in the UNOS registry who donated ≥1 organ for transplantation between 2007 and 2018 were included. Nonideal donors had any of age>50, smoking history ≥20 pack-years, PaO2 /FiO2 ratio ≤350, donation after circulatory death, or increased risk status. OPO-level risk aversion in donor pursuit, consent attainment, lung recovery, and transplantation was assessed. Among 83916 donors, 70372 (83.9%) were nonideal. Unadjusted OPO-level rates of nonideal donor pursuit ranged from 81 to 100%. In a three-tier system of overall risk aversion, tier 3 OPOs (least risk-averse) had the highest rates of nonideal donor pursuit, consent attainment, lung recovery, and transplantation. Tier 1 OPOs (most risk-averse) had the lowest rates of donor pursuit, consent attainment, and lung recovery, but higher rates of transplantation compared to tier 2 OPOs (moderately risk-averse). Risk aversion varies among OPOs and across the donation process. OPO evaluations should reflect early donation process stages to best differentiate over- and underperforming OPOs and encourage optimal OPO-specific performance.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

March 2021

Volume

21

Issue

3

Start / End Page

1269 / 1277

Location

United States

Related Subject Headings

  • Tissue and Organ Procurement
  • Tissue Donors
  • Surgery
  • Registries
  • Organ Transplantation
  • Middle Aged
  • Lung
  • Humans
  • Adult
  • 3204 Immunology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Halpern, S. E., McConnell, A., Peskoe, S. B., Raman, V., Jawitz, O. K., Choi, A. Y., … Hartwig, M. G. (2021). A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs. Am J Transplant, 21(3), 1269–1277. https://doi.org/10.1111/ajt.16347
Halpern, Samantha E., Alec McConnell, Sarah B. Peskoe, Vignesh Raman, Oliver K. Jawitz, Ashley Y. Choi, Megan L. Neely, Scott M. Palmer, and Matthew G. Hartwig. “A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs.Am J Transplant 21, no. 3 (March 2021): 1269–77. https://doi.org/10.1111/ajt.16347.
Halpern SE, McConnell A, Peskoe SB, Raman V, Jawitz OK, Choi AY, et al. A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs. Am J Transplant. 2021 Mar;21(3):1269–77.
Halpern, Samantha E., et al. “A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs.Am J Transplant, vol. 21, no. 3, Mar. 2021, pp. 1269–77. Pubmed, doi:10.1111/ajt.16347.
Halpern SE, McConnell A, Peskoe SB, Raman V, Jawitz OK, Choi AY, Neely ML, Palmer SM, Hartwig MG. A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs. Am J Transplant. 2021 Mar;21(3):1269–1277.
Journal cover image

Published In

Am J Transplant

DOI

EISSN

1600-6143

Publication Date

March 2021

Volume

21

Issue

3

Start / End Page

1269 / 1277

Location

United States

Related Subject Headings

  • Tissue and Organ Procurement
  • Tissue Donors
  • Surgery
  • Registries
  • Organ Transplantation
  • Middle Aged
  • Lung
  • Humans
  • Adult
  • 3204 Immunology